{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:18:40Z","timestamp":1793035120131,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41390-022-02211-8","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T11:03:38Z","timestamp":1660907018000},"page":"1250-1257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Propranolol ameliorates retinopathy of prematurity in mice by downregulating HIF-1\u03b1 via the PI3K\/Akt\/ERK pathway"],"prefix":"10.1038","volume":"93","author":[{"given":"Shaomin","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"2211_CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajo.2009.04.018","volume":"148","author":"EM Lad","year":"2009","unstructured":"Lad, E. M., Hernandez-Boussard, T., Morton, J. M. & Moshfeghi, D. M. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am. J. Ophthalmol. 148, 451\u2013458 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"2211_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","volume":"84","author":"C Gilbert","year":"2008","unstructured":"Gilbert, C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum. Dev. 84, 77\u201382 (2008).","journal-title":"Early Hum. Dev."},{"key":"2211_CR3","first-page":"68","volume":"75","author":"LM Wolforth","year":"2016","unstructured":"Wolforth, L. M., Loo, S. W. & Sood, S. L. Retinopathy of prematurity and ethnicity in Hawai\u2019i: a retrospective study (1996 - 2006) of medical records from Kapi\u2019olani Medical Center for Women and Children. Hawaii J. Med. Public Health 75, 68\u201372 (2016).","journal-title":"Hawaii J. Med. Public Health"},{"key":"2211_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.2004-1413","volume":"116","author":"WV Good","year":"2005","unstructured":"Good, W. V. et al. The incidence and course of retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity Study. Pediatrics 116, 15\u201323 (2005).","journal-title":"Pediatrics"},{"key":"2211_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09286586.2018.1562082","volume":"26","author":"D Dhingra","year":"2019","unstructured":"Dhingra, D. et al. Change in the incidence and severity of retinopathy of prematurity (ROP) in a neonatal intensive care unit in Northern India after 20 years: comparison of two similar prospective cohort studies. Ophthalmic. Epidemiol. 26, 169\u2013174 (2019).","journal-title":"Ophthalmic. Epidemiol."},{"key":"2211_CR6","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.12659\/MSM.890688","volume":"20","author":"Q Liu","year":"2014","unstructured":"Liu, Q. et al. Incidence of retinopathy of prematurity in Southwestern China and analysis of risk factors. Med. Sci. Monit. 20, 1442\u20131451 (2014).","journal-title":"Med. Sci. Monit."},{"key":"2211_CR7","first-page":"273","volume":"26","author":"XQ Luo","year":"2010","unstructured":"Luo, X. Q. et al. Prevalence of retinopathy of prematurity in some tertiary hospitals in Guangdong Province. Chin. J. Ocul. Fundus Dis. 26, 273\u2013275 (2010).","journal-title":"Chin. J. Ocul. Fundus Dis."},{"key":"2211_CR8","unstructured":"Zhu, L. Incidence Rate and Risk Factors of Retinopathy of Prematurity from a Multicenter Study. (Fudan University, 2006)."},{"key":"2211_CR9","unstructured":"Tian, N. The Screening and Results in the Analysis of Premature Retinopathy in the Panyu District of Guangzhou City. (Southern Medical University, 2013)."},{"key":"2211_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe, H., Lawn, J. E., Vazquez, T., Fielder, A. & Gilbert, C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr. Res. 74, 35\u201349 (2013).","journal-title":"Pediatr. Res."},{"key":"2211_CR11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/archdischild-2016-310532","volume":"102","author":"AL Solebo","year":"2017","unstructured":"Solebo, A. L., Teoh, L. & Rahi, J. Epidemiology of blindness in children. Arch. Dis. Child 102, 853\u2013857 (2017).","journal-title":"Arch. Dis. Child"},{"key":"2211_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/ijms20030490","volume":"20","author":"AM Mercurio","year":"2019","unstructured":"Mercurio, A. M. VEGF\/neuropilin signaling in cancer stem cells. Int. J. Mol. Sci. 20, 490 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2211_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/EB.S94449","volume":"8","author":"H Wang","year":"2016","unstructured":"Wang, H. Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy. Eye Brain 8, 81\u201390 (2016).","journal-title":"Eye Brain"},{"key":"2211_CR14","doi-asserted-by":"crossref","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","volume":"2007","author":"GL Semenza","year":"2007","unstructured":"Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, cm8 (2007).","journal-title":"Sci. STKE"},{"key":"2211_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuint.2019.03.008","volume":"128","author":"Y Miwa","year":"2019","unstructured":"Miwa, Y. et al. Pharmacological HIF inhibition prevents retinal neovascularization with improved visual function in a murine oxygen-induced retinopathy model. Neurochem. Int. 128, 21\u201331 (2019).","journal-title":"Neurochem. Int."},{"key":"2211_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1267\/ahc.10038","volume":"44","author":"P Wang","year":"2011","unstructured":"Wang, P. et al. Protein Kinase B (Akt) promotes pathological angiogenesis in murine model of oxygen-induced retinopathy. Acta Histochem. Cytochem. 44, 103\u2013111 (2011).","journal-title":"Acta Histochem. Cytochem."},{"key":"2211_CR17","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3892\/ijmm.2015.2371","volume":"36","author":"Y Di","year":"2015","unstructured":"Di, Y., Zhang, Y., Nie, Q. & Chen, X. Ccn1\/Cyr61-Pi3k\/Akt signaling promotes retinal neovascularization in oxygen-induced retinopathy. Int. J. Mol. Med. 36, 1507\u20131518 (2015).","journal-title":"Int. J. Mol. Med."},{"key":"2211_CR18","first-page":"2463","volume":"9","author":"Y Di","year":"2015","unstructured":"Di, Y., Zhang, Y., Yang, H., Wang, A. & Chen, X. The mechanism of Ccn1-enhanced retinal neovascularization in oxygen-induced retinopathy through Pi3k\/Akt-Vegf signaling pathway. Drug Des. Devel. Ther. 9, 2463\u20132473 (2015).","journal-title":"Drug Des. Devel. Ther."},{"key":"2211_CR19","doi-asserted-by":"crossref","first-page":"38205","DOI":"10.1074\/jbc.M203781200","volume":"277","author":"R Fukuda","year":"2002","unstructured":"Fukuda, R. et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on map kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205\u201338211 (2002).","journal-title":"J. Biol. Chem."},{"key":"2211_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1167\/iovs.10-5536","volume":"52","author":"C Ristori","year":"2011","unstructured":"Ristori, C. et al. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Invest. Ophthalmol. Vis. Sci. 52, 155\u2013170 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2211_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","volume":"111","author":"M Dal Monte","year":"2013","unstructured":"Dal Monte, M. et al. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice. Exp. Eye Res. 111, 27\u201335 (2013).","journal-title":"Exp. Eye Res."},{"key":"2211_CR22","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.bbrc.2018.08.041","volume":"503","author":"JH Yun","year":"2018","unstructured":"Yun, J. H. et al. Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy. Biochem. Biophys. Res. Commun. 503, 2792\u20132799 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2211_CR23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","volume":"163","author":"L Filippi","year":"2013","unstructured":"Filippi, L. et al. Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J. Pediatr. 163, 1570\u20131577.e1576 (2013).","journal-title":"J. Pediatr."},{"key":"2211_CR24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12887-017-0923-8","volume":"17","author":"L Filippi","year":"2017","unstructured":"Filippi, L. et al. Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial. BMC Pediatr. 17, 165 (2017).","journal-title":"BMC Pediatr."},{"key":"2211_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(86)80250-9","volume":"7","author":"LM Friedman","year":"1986","unstructured":"Friedman, L. M. et al. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. J. Am. Coll. Cardiol. 7, 1\u20138 (1986).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2211_CR26","first-page":"131","volume":"54","author":"XR Huang","year":"2016","unstructured":"Huang, X. R., Wang, Y. J., Yang, G. R., Yang, Z. X. & Zhang, J. S. The effect of propranolol on oxygen-induced retinal neovascularization. Chin. J. Pediatr. 54, 131\u2013136 (2016).","journal-title":"Chin. J. Pediatr."},{"key":"2211_CR27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/09286586.2019.1606259","volume":"26","author":"GS Ying","year":"2019","unstructured":"Ying, G. S., Bell, E. F., Donohue, P., Tomlinson, L. A. & Binenbaum, G. Perinatal risk factors for the retinopathy of prematurity in postnatal growth and ROP study. Ophthalmic. Epidemiol. 26, 270\u2013278 (2019).","journal-title":"Ophthalmic. Epidemiol."},{"key":"2211_CR28","first-page":"80","volume":"18","author":"H-C Gao","year":"2018","unstructured":"Gao, H.-C., Chen, C., Zhang, Y.-Q. & Zhang, J.-M. Progress on study of the risk factors of retinopathy of prematurity. Int. Eye Sci. 18, 80\u201383 (2018).","journal-title":"Int. Eye Sci."},{"key":"2211_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/j.1552-4604.1984.tb02772.x","volume":"24","author":"MA Weber","year":"1984","unstructured":"Weber, M. A., Drayer, J. I. & Kaufman, C. A. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences. J. Clin. Pharm. 24, 103\u2013112 (1984).","journal-title":"J. Clin. Pharm."},{"key":"2211_CR30","first-page":"1159","volume":"82","author":"OK Andersson","year":"1985","unstructured":"Andersson, O. K., Widgren, B. & Berglund, G. A 10-year follow-up of men with mild hypertension. bendroflumethiazide and propranolol give equal effect in treatment of high blood pressure. Lakartidningen 82, 1159\u20131162 (1985).","journal-title":"Lakartidningen"},{"key":"2211_CR31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/0002-8703(85)90709-4","volume":"109","author":"PA Chandraratna","year":"1985","unstructured":"Chandraratna, P. A. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials. Am. Heart J. 109, 1198\u20131204 (1985).","journal-title":"Am. Heart J."},{"key":"2211_CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/CAD.0000000000000762","volume":"30","author":"J Huang","year":"2019","unstructured":"Huang, J., Jiang, D., Zhao, S. & Wang, A. Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating Mir-125b expression. Anticancer Drugs 30, 501\u2013507 (2019).","journal-title":"Anticancer Drugs"},{"key":"2211_CR33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/IOP.0000000000001336","volume":"35","author":"M Jamshidian-Tehrani","year":"2019","unstructured":"Jamshidian-Tehrani, M. et al. Clinical and ultrasonographic evaluation of infantile periocular hemangioma treated with oral propranolol. Ophthalmic. Plast. Reconstr. Surg. 35, 484\u2013486 (2019).","journal-title":"Ophthalmic. Plast. Reconstr. Surg."},{"key":"2211_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1297\/cpe.28.9","volume":"28","author":"A Osada","year":"2019","unstructured":"Osada, A., Araki, E., Yamashita, Y. & Ishii, T. Combination therapy of propranolol, levothyroxine, and liothyronine was effective in a case of severe consumptive hypothyroidism associated with infantile hepatic hemangioma. Clin. Pediatr. Endocrinol. 28, 9\u201314 (2019).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"2211_CR35","first-page":"131","volume":"54","author":"X Huang","year":"2016","unstructured":"Huang, X., Wang, Y., Yang, G., Yang, Z. & Zhang, J. Effects of propranolol on oxygen-induced retinal neovascularization in mouse. Zhonghua Er Ke Za Zhi 54, 131\u2013136 (2016).","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2211_CR36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fncel.2017.00395","volume":"11","author":"M Cammalleri","year":"2017","unstructured":"Cammalleri, M. et al. The beta adrenergic receptor blocker propranolol counteracts retinal dysfunction in a mouse model of oxygen induced retinopathy: restoring the balance between apoptosis and autophagy. Front. Cell Neurosci. 11, 395 (2017).","journal-title":"Front. Cell Neurosci."},{"key":"2211_CR37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.lfs.2012.07.019","volume":"91","author":"A Villalvilla","year":"2012","unstructured":"Villalvilla, A. et al. Circulating endothelial progenitor cells are reduced in rat oxygen-induced retinopathy despite a retinal Sdf-1\/Cxcr4 and VEGF proangiogenic response. Life Sci. 91, 264\u2013270 (2012).","journal-title":"Life Sci."},{"key":"2211_CR38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jcmm.13348","volume":"22","author":"F Pisani","year":"2018","unstructured":"Pisani, F. et al. Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of Aqp4. J. Cell Mol. Med. 22, 613\u2013627 (2018).","journal-title":"J. Cell Mol. Med"},{"key":"2211_CR39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00441-014-2104-5","volume":"360","author":"L Dong","year":"2015","unstructured":"Dong, L. et al. PTB-associated splicing factor inhibits IGF-1-induced VEGF upregulation in a mouse model of oxygen-induced retinopathy. Cell Tissue Res. 360, 233\u2013243 (2015).","journal-title":"Cell Tissue Res."},{"key":"2211_CR40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/cells8040288","volume":"8","author":"M Stevens","year":"2019","unstructured":"Stevens, M. & Oltean, S. Modulation of receptor tyrosine kinase activity through alternative splicing of ligands and receptors in the VEGF-A\/VEGFR axis. Cells 8, 288 (2019).","journal-title":"Cells"},{"key":"2211_CR41","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.7150\/jca.25370","volume":"9","author":"G Li","year":"2018","unstructured":"Li, G. et al. VEGFR-2 inhibitor apatinib hinders endothelial cells progression triggered by irradiated gastric cancer cells-derived exosomes. J. Cancer 9, 4049\u20134057 (2018).","journal-title":"J. Cancer"},{"key":"2211_CR42","doi-asserted-by":"crossref","first-page":"e0201395","DOI":"10.1371\/journal.pone.0201395","volume":"13","author":"Y Mao","year":"2018","unstructured":"Mao, Y., Liu, X., Song, Y., Zhai, C. & Zhang, L. VEGF-A\/VEGFR-2 and FGF-2\/FGFR-1 but not PDGF-BB\/PDGFR-\u0392 play important roles in promoting immature and inflammatory intraplaque angiogenesis. PLoS One 13, e0201395 (2018).","journal-title":"PLoS One"},{"key":"2211_CR43","first-page":"55","volume":"8","author":"DS McLeod","year":"2016","unstructured":"McLeod, D. S. & Lutty, G. A. Targeting VEGF in canine oxygen-induced retinopathy \u2013 a model for human retinopathy of prematurity. Eye Brain 8, 55\u201365 (2016).","journal-title":"Eye Brain"},{"key":"2211_CR44","volume":"8","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis. Nat. Commun. 8, 584 (2017).","journal-title":"Nat. Commun."},{"key":"2211_CR45","first-page":"1457","volume":"54","author":"X Jin","year":"2019","unstructured":"Jin, X. et al. Netrin-1 interference potentiates epithelial-to-mesenchymal transition through the Pi3k\/Akt pathway under the hypoxic microenvironment conditions of non-small cell lung cancer. Int J. Oncol. 54, 1457\u20131465 (2019).","journal-title":"Int J. Oncol."},{"key":"2211_CR46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.gene.2019.03.051","volume":"700","author":"F Hu","year":"2019","unstructured":"Hu, F., He, Z., Sun, C. & Rong, D. Knockdown of Grhl2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the Pi3k\/Akt pathway. Gene 700, 96\u2013104 (2019).","journal-title":"Gene"},{"key":"2211_CR47","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1470-2045(18)30905-7","volume":"20","author":"PA Konstantinopoulos","year":"2019","unstructured":"Konstantinopoulos, P. A. et al. Olaparib and \u0391-specific Pi3k inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Lancet Oncol. 20, 570\u2013580 (2019).","journal-title":"Lancet Oncol."},{"key":"2211_CR48","first-page":"3547","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z., Yao, L., Yang, J., Wang, Z. & Du, G. Pi3k\/Akt and Hif-1 signaling pathway in hypoxia-ischemia (review). Mol. Med. Rep. 18, 3547\u20133554 (2018).","journal-title":"Mol. Med. Rep."},{"key":"2211_CR49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/156800908783497122","volume":"8","author":"BH Jiang","year":"2008","unstructured":"Jiang, B. H. & Liu, L. Z. Akt signaling in regulating angiogenesis. Curr. Cancer Drug Targets 8, 19\u201326 (2008).","journal-title":"Curr. Cancer Drug Targets"},{"key":"2211_CR50","volume":"7","author":"S Gao","year":"2017","unstructured":"Gao, S. et al. PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy. Sci. Rep. 7, 42846 (2017).","journal-title":"Sci. Rep."},{"key":"2211_CR51","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith, L. E. et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol. Vis. Sci. 35, 101\u2013111 (1994).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"2211_CR52","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1167\/iovs.12-9691","volume":"53","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. Propranolol inhibition of \u0392-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 53, 2968\u20132977 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2211_CR53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2012.08.014","volume":"1478","author":"MR Romano","year":"2012","unstructured":"Romano, M. R. et al. Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats. Brain Res. 1478, 55\u201363 (2012).","journal-title":"Brain Res."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02211-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02211-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02211-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T15:16:09Z","timestamp":1682522169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02211-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02211-8","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"28 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}